News

Optime Care, Specialty Pharmacy Patient Management Organization Announces Enhanced Partnership with Rigel Pharmaceuticals, Inc. for Rezlidhia™ Patients

By | Articles, News

ST. LOUIS, Mo.–(BUSINESS WIRE)–Optime Care, a member of the AscellaHealth Family of Companies, today announced a contractual partnership with Rigel Pharmaceuticals, Inc., bringing its full suite patient support/HUB service capabilities to support Rezlidhia™(olutasidenib), a recent FDA-approved treatment for adult patients with relapse or refractory acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test. Optime Care’s services for life sciences manufacturers include pre-commercialization and market access expertise, exclusive distribution partnerships, national medication fulfillment and high-touch patient support and HUB services for enhanced patient outcomes.

To read more, click here.

Acknowledging Caregivers and Their Significant Impact on Loved Ones with Rare Diseases

By | Articles, News

National Caregivers Month, November 2022

During November, National Family Caregivers Month and throughout the year, Optime Care is proud to recognize caregivers and express its appreciation for those providing essential care for rare disease patients and those with chronic, complex conditions.

Over 53 million family members provide care to a loved one each year, with 20 million new caregivers joining this force yearly.

Family members tasked with responsibilities to care for individuals with rare diseases and chronic conditions must overcome healthcare issues and address complex and challenging symptoms. These responsibilities are ongoing and can become overwhelming for caregivers who often lack the experience and training required to care for a loved one.

We also appreciate that the time required to deal with the rare diseases of a loved one takes time away from spending it on personal activities and family interactions. The entire caregiving experience can be emotional, with many caregivers reporting anxiety or depression. Finally, many families report that their financial situations have been impacted with caregivers often forced to give up full-time employment in order provide the level of care needed. Many also opt to work part-time instead of full-time.

For these and other reasons, Optime Care’s specialty pharmacists and care coordinators passionately assist patients and caregivers throughout the healthcare journey. They provide  expertise and high-level coordinated support services to offer guidance and help ease the pressures on caregivers.

 

Learn more about how Optime Care’s pharmacists and care coordinators support caregivers and patients with rare diseases and complex, chronic conditions here.

Optime Care Recognizes Role of Caregivers for Individuals with Rare Disease, Chronic, Complex Conditions

By | Articles, News

EARTH CITY, Mo.–(BUSINESS WIRE)–Optime Care, a national specialty pharmacy, distribution and patient management organization, maximizing therapeutic opportunities for the treatment of orphan and rare disorders, is pleased to recognize November as National Family Caregivers Month and expresses its appreciation for caregivers across the nation who are providing essential care for rare disease patients and those with chronic, complex conditions.

To read more, click here.

Optime Care, a Specialty Pharmacy and Patient Services Organization, Recognizes the Critical Role of Pharmacists During American Pharmacist Month, October 2022

By | Articles, News

Recognizing our own Brandon Salke, Pharm.D., General Manager and Pharmacist-in-Charge who was recently honored in the Next-Generation Pharmacist Awards and named Specialty Pharmacist of the Year by Pharmacy Times and Parata Systems. 

American Pharmacists Month (APhM) is hosted by the American Pharmacist Association (APhA) to celebrate the nation’s pharmacists and show appreciation for their important role in communities.

For rare disease patients and those living with complex, chronic conditions, pharmacists play an integral role in supporting the patient’s health and treatment journey. Specialty pharmacists possess condition-specific rare disease expertise, allowing for unmatched depth and breadth of care.

APhM is also a great opportunity to thank Brandon Salke, pharmacist-in-charge at Optime Care, for his commitment to serving Optime Care’s clients and rare disease patients and the community. Working with experienced patient care coordinators and the entire staff, Salke and team deliver exemplary support with a patient-first approach that addresses not only the physical aspects of a patient’s condition but also the burdens that rare disease place upon the mental health of patients and their caregivers.

Brandon is well-deserving of the award and was one of 31 finalists selected by a panel of industry experts in a broad range of pharmacy sectors including large chain retailers, independent pharmacies, specialty pharmacies, military bases, health clinics and educational institutions.

 

Specialty Pharmacists

Rare diseases are conditions that impact less than 200,000 people in the United States. Because these conditions are less common, these patients need specialized care and ongoing support throughout their treatment. Specialty pharmacists develop personal connections to help ensure patients stay compliant to therapy so they can achieve the best possible clinical outcomes.

 

Optime Care specialty pharmacists and care coordinators utilize their clinical skills, deep rare disease expertise and custom clinical programs to better manage patients with rare and orphan diseases.

With patient-first distribution and patient management programs, Optime Care’s specialty pharmacists can create deeper connections, offer more personalized care and enhance clinical outcomes of patients with rare and orphan diseases.

 

Learn more about how Optime Care’s pharmacists and care coordinators support patients with rare diseases and complex, chronic conditions here.

Optime Care General Manager, Brandon Salke, Pharm.D. Named Specialty Pharmacist of the Year in Prestigious 2022 Next-Generation Pharmacist Awards

By | Articles, News

EARTH CITY, Mo.–(BUSINESS WIRE)–Optime Care, a national specialty pharmacy, distribution and patient management organization maximizing therapeutic opportunities for the treatment of orphan and rare disorders, is thrilled to announce that Brandon Salke, Pharm.D., general manager and pharmacist-in-charge, Optime Care has been named Specialty Pharmacist of the Year by Pharmacy Times and Parata Systems in the 2022 Next-Generation Pharmacist Awards. The recognition is a peer-nominated awards program and Salke was one of 31 finalists selected by a panel of industry experts in a broad range of pharmacy sectors including large chain retailers, independent pharmacies, specialty pharmacies, military bases, health clinics and educational institutions.

To read more, Click Here.

Help Optimize Care for Orphan, Rare Lung Diseases Amid COVID-19 Pandemic

By | Articles, News

The value of a patient-first approach and telehealth for addressing the complex health coordination needs of those with these pulmonary conditions has never been more critical.

Rare lung diseases, defined as those that affect fewer than 200,000 individuals, affect a wide array of individuals.1

These diseases include a spectrum of disorders, including alpha-1 antitrypsin deficiency (Alpha-1), hereditary interstitial lung diseases, lymphangioleimyomatosis, pulmonary alveolar proteinosis, and tuberous sclerosis.

To read more, Click Here.

Optime Care Recognizes Gene Therapy and Specialty Pharmacy Awareness Month, September 2022

By | Articles, News

EARTH CITY, Mo.–(BUSINESS WIRE)–Optime Care, a nationally recognized specialty pharmacy, distribution and patient management organization maximizing therapeutic opportunities for the treatment of orphan and rare disorders, announces its support of the inaugural Gene Therapy and Specialty Pharmacy Awareness month, September 2022. The observance is included in the annual Calendar of Health Observances & Recognition Days, published by The Society for Health Care Strategy & Market Development (SHSMD) of the American Hospital Association and was founded by its parent company, AscellaHealth Family of Companies.

To read more, Click Here.

6 Last Mile Considerations for Rare Disease Therapies

By | Articles, News

A specialty pharmacist discusses the added communication and support—including manufacturers working with patient groups—that foster adherence among smaller patient populations.

Many patients with rare diseases use temperature-controlled therapies to manage symptoms. With smaller patient populations and batch volumes, special handling is often required to ensure these expensive drugs arrive safely. Brandon Salke, Pharm.D, is pharmacist-in-charge at Optime Care, a specialty pharmacy, distribution, and patient management organization focusing on rare, orphan and ultra-orphan products. He discusses that while not all patients in these populations have mobility issues, these therapies have different last mile and two-way communication practices compared to traditional drugs.

To read more, Click Here.

Optime Care Receives 2022 Sales and Marketing Technology Award

By | Articles, News

Earth City, MO —August 4, 2022—Today, the Business Intelligence Group named Optime Care Organization of the Year in the 2022 Sales and Marketing Technology Awards program, also known as The Sammys. The Sammys honor organizations connecting and collaborating with prospects and customers.

Darcey McDermott, Chief Marketing and Communications Officer, AscellaHealth Family of Companies and parent company to Optime Care, states, “We are thrilled to be honored on this list of esteemed companies. Optime Care earned this recognition based upon the corporate marketing team’s social media outreach on disease state education and awareness and advocacy information. Our social channels provide a stronger voice to patients and all stakeholders in the orphan and rare disease community.”

The Sammys recognize companies for leadership and vision to educate and connect with customers. Optime Care is recognized as an Organization of the Year for social media content that informs patients with rare diseases of the latest news relevant to them and brings together all stakeholders in the Specialty Pharmacy industry from pharmaceutical manufacturers to patient care coordinators.

Tiffany Burt, President and COO, Optime Care says, “The low prevalence of orphan diseases leaves many patients with few resources and difficulties accessing care and treatment,” continues Burt. “This is precisely where Optime Care fills the void. Our dedicated team of professionals focuses solely on rare disease patients, always puts them first and works diligently to ensure streamlined access to care that results in improved outcomes and quality of life.”

“We are proud to reward and recognize Optime Care for their innovation and dedication to helping both the organization using their technology and the ultimate consumer,” said Maria Jimenez, Chief Nominations Officer, Business Intelligence Group. “It was clear to our judges that their efforts will improve how we all connect with the brands we love for years to come.”

About Optime Care

Optime Care, Inc. is a nationally recognized specialty pharmacy, distribution and patient management organization offering a suite of comprehensive services tailored to maximize the therapeutic opportunities for the treatment of orphan and rare disorders. Our executive team has partnered in the launch and management of over 40 orphan products and programs while consistently implementing the best brand services for the community. Our experience with small patient populations, coupled with our strategic partnership with AscellaHealth, enhances our services and ability to serve the specialty pharmacy market. Optime Care has dual-accreditation from the Utilization Review Accreditation Commission (URAC) for compliance with specialty pharmacy and the Accreditation Commission for Health Care (ACHC) for specialty pharmacy services that demonstrate a commitment to providing quality care and services to consumers. https://www.optimecare.com

About Business Intelligence Group

The Business Intelligence Group was founded with the mission of recognizing true talent and superior performance in the business world. Unlike other industry award programs, business executives—those with experience and knowledge—judge the programs. The organization’s proprietary and unique scoring system selectively measures performance across multiple business domains and then rewards those companies whose achievements stand above those of their peers.

 

Contact

Maria Jimenez
Chief Nominations Officer
Business Intelligence Group
1 909-529-2737
jmaria@bintelligence.com

Patient-First Strategy Optimizes Therapeutic Value of Specialty Drugs for Patients with Rare Cancers

By | News

National Cancer Survivors Month June 2022

This June 2022, National Cancer Survivors Month, Optime Care joins other leading healthcare organizations to recognize cancer survivors, raise awareness of the ongoing challenges cancer survivors face and celebrate life.
With nearly 17 million people living with cancer in the U.S. today – and more than 43 million cancer survivors worldwide – everyone is touched in some way by cancer.

We also want to highlight the benefits of Optime Care’s patient-first approach for rare oncology patients. We put the patient at the center of care to address their specific issues and improve outcomes and quality of life.

Challenges for Rare Cancer Patients

Rare cancers comprise a multitude of cancer types affecting an array of patient populations. We believe that a one-size-fits-all approach is insufficient to address all their needs and prefer to tailor our care based upon each patient’s unique needs and aspects of each rare cancer.

Our approach to specialty oncology pharmacy management is designed to reduce costs, increase specialty drug availability and improve patient outcomes through appropriate medication therapy management.

Optime Care’s Enhanced Patient Care Management

We begin by ensuring prescription accuracy, compliance, adherence to treatment and side effects management, and by offering counseling, guidance and education based upon each patient and caregiver’s particular requirements.
With effective management of the complications of chronic illness and rare cancers, our team strives to mitigate unnecessary costs, and provide the best possible clinical outcomes and patient experience.

This National Cancer Survivors Month, join us by taking action to increase public awareness and improve the lives of cancer survivors.

To learn more visit here.